| __timestamp | Corcept Therapeutics Incorporated | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 2704597 |
| Thursday, January 1, 2015 | 15419000 | 15470000 |
| Friday, January 1, 2016 | 23844000 | 28037000 |
| Sunday, January 1, 2017 | 40376000 | 71615000 |
| Monday, January 1, 2018 | 75247000 | 99828000 |
| Tuesday, January 1, 2019 | 89017000 | 166023000 |
| Wednesday, January 1, 2020 | 114764000 | 201727000 |
| Friday, January 1, 2021 | 113864000 | 259039000 |
| Saturday, January 1, 2022 | 130991000 | 294781000 |
| Sunday, January 1, 2023 | 184353000 | 344077000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc. have demonstrated a steadfast commitment to advancing medical science through substantial R&D expenditures.
From 2014 to 2023, Corcept Therapeutics increased its R&D spending by an impressive 900%, reflecting a strategic focus on developing groundbreaking therapies. This growth underscores the company's dedication to addressing unmet medical needs.
Iovance Biotherapeutics, on the other hand, has seen its R&D investments skyrocket by over 12,000% during the same period. This remarkable surge highlights Iovance's aggressive pursuit of innovative cancer treatments, positioning it as a leader in the biotech sector.
Both companies exemplify the transformative power of R&D in driving medical advancements and improving patient outcomes.
Research and Development: Comparing Key Metrics for Merck & Co., Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: GSK plc vs Corcept Therapeutics Incorporated
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and PTC Therapeutics, Inc.
TG Therapeutics, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Iovance Biotherapeutics, Inc.
R&D Insights: How Iovance Biotherapeutics, Inc. and Travere Therapeutics, Inc. Allocate Funds
R&D Insights: How Iovance Biotherapeutics, Inc. and Evotec SE Allocate Funds